Shares of healthcare solutions provider Healtheon/WebMD (Nasdaq: HLTH) climbed more than eight percent on Friday, gaining 3-1/16 to 41-3/16 after receiving a strong buy rating from Warburg Dillon Read. The investment firm gave Healtheon/WebMD a $60 price target, noting that the company is well positioned to capitalize on the growth of e-commerce in the healthcare sector.
On Wednesday, Healtheon/WebMD announced an alliance with Humana, a managed healthcare company with approximately six million members. Humana will promote Healtheon/WebMD’s offerings to its members and physicians, while Healtheon/WebMD will provide content for consumers and healthcare providers in at least three of Humana’s markets. PaineWebber initiated coverage of Healtheon/WebMD with a buy rating on Wednesday.